Lakeview-backed UAS Laboratories buys IP assets of Micropharma
UAS Laboratories LLC has purchased certain intellectual property assets of Micropharma Ltd, a Montréal-based developer of theraputics, diagnostics and devices based on the human microbiome. The financial terms of the deal were not disclosed. UAS Labs said the acquisition will support its objective to provide probiotic-based health solutions worldwide. Headquartered in Wausau, Wisconsin, UAS Labs was acquired by U.S. private equity firm Lakeview Equity Partners in 2013. A spin-off of McGill University, Micropharma was founded in 2004 and has been backed by private investors.
2 December 2014•3 mins read
